Enzolytics Inc (ENZC)

[God_Father]

It's incredible how far they've come. They have proposals from multiple "companies". On the vetinary side they could end up going with one or multiple licensing agreements. I posted a list of the top 10 vetinary health companies and the Top 3 were Merck, Zoetis, and Boehringer, all of which are multi-billion dollar companies. Boehringer is interesting because they are not only a pharmaceutical company, but are also a CDMO in which case if did business with them they would provide end-to-end services. Zoetis is also an interesting choice because of the location and fact they have a strong working relationship with Fuji which is also a CDMO.

On the human mAb side, we identified Samsung as the CDMO but have not yet announced any licensing agreements for pharmaceutical companies. Could be one or multiple Merck, J&J, Gilead, Eli Lilly, etc.

Eitherway, this is an exciting time since we have multiple licensing agreements and uplisting seemingly around the corner. These to me are all major catalysts, progressively more significant than any that we've had before. This all needs to materialize in 2022 well before clinical trials begin as part of future agreements as the licensees will likely fund the monoclonal antibodies. There is no way we go into clinical trials ourselves and would be crazy to fund all 20+ products given that it cost on average $20MM per clinical. With Samsung's S-cellerate program being able to significantly reduce time to get to an IND (9 months), early next year looks prime and promising. My guess is we'll see the bulk of these agreements executed in Q1-Q2 of next year. Don't think it'll take long if they already have proposals in hand.